Clinical Trials on Alkalosis, Respiratory in Argentina
Total 827 results
-
AstraZenecaAmgenRecruitingAsthmaUnited States, Poland, Korea, Republic of, Spain, France, China, United Kingdom, Canada, Netherlands, Argentina, Mexico, Brazil, Hungary, Japan, Philippines, South Africa, Colombia
-
PfizerCompletedMaxillary SinusitisUnited States, Costa Rica, Chile, India, Slovakia, Argentina, Czech Republic, Estonia, Germany, Lithuania, Mexico, Poland, Russian Federation
-
AmgenCompletedCOVID-19United States, Russian Federation, Mexico, Brazil, South Africa, Argentina, Chile, Ukraine
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Poland, Russian Federation, Belgium, Canada, Chile, France, Germany, Korea, Republic of, Netherlands, Peru, Philippines, South Africa, Sweden, Thailand
-
Hospital Universitario GetafeCompletedAcute Respiratory FailureUnited States, Netherlands, China, Colombia, Spain, Egypt, Canada, France, Australia, New Zealand, Argentina, Germany, India, Ecuador, Japan, Korea, Republic of, Uruguay, Bolivia, Brazil, Chile, Denmark, Greece, Hungary, Italy, Mexico, Mo... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Chile, Romania, Canada
-
Hoffmann-La RocheRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, China, Japan, Australia, Taiwan, Brazil, Argentina, Hong Kong
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, United States, Argentina, Canada, Germany, Italy, Netherlands, Portugal, Russian Federation, Ukraine, United Kingdom
-
Incyte CorporationRecruitingModerate to Severe AsthmaKorea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
-
GlaxoSmithKlineTerminatedHypertensionSpain, Germany, Korea, Republic of, Canada, Japan, Netherlands, United Kingdom, Czechia, United States, China, Austria, Israel, Argentina, Russian Federation, Mexico, Saudi Arabia
-
GlaxoSmithKlineTerminatedHypertensionSpain, Germany, Korea, Republic of, Canada, Japan, Netherlands, United Kingdom, United States, China, Austria, Israel, Argentina, Russian Federation, Mexico, Saudi Arabia, Czech Republic
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerItaly, United States, Argentina, Belgium, Germany, Israel, Poland, Spain, Turkey, Australia, Chile, France
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingCOVID-19United States, Singapore, Japan, Ukraine, Georgia, Korea, Republic of, Australia, Denmark, Thailand, Greece, South Africa, Germany, Uganda, Spain, Puerto Rico, Argentina, Nigeria, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Canada, Finland, France, Germany, Hungary, Italy, Spain, United Kingdom
-
CanSino Biologics Inc.Beijing Institute of BiotechnologyCompletedCOVID-19Mexico, Argentina, Chile, Pakistan, Russian Federation
-
Spectrum Pharmaceuticals, IncCompletedNon-small Cell Lung CancerUnited States, Czechia, India, Brazil, Argentina, Hungary
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Romania, Russian Federation, Spain, Bulgaria, Canada, Hungary, Argentina
-
Bond Avillion 2 Development LPCompletedAsthmaUnited States, Germany, Ukraine, Serbia, Czechia, Argentina, Slovakia
-
Novartis PharmaceuticalsCompletedAsthmaGermany, United States, South Africa, Hungary, Turkey, Slovakia, Argentina, Philippines, Mexico, Saudi Arabia
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Germany, Poland, Romania, Russian Federation, Ukraine, Canada, Chile, France, Korea, Republic of, United Kingdom
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, United States, Belgium, Poland, Latvia, Argentina, Guatemala, Philippines, Slovakia, Czechia, Hungary, Russian Federation, Japan, Bulgaria, Canada
-
MedImmune LLCCompletedAsthmaUnited States, Czech Republic, France, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, United Kingdom, Germany, Philippines, Argentina, Canada, Chile, Japan
-
Nabriva Therapeutics AGCompletedCommunity Acquired PneumoniaUnited States, Argentina, Brazil, Bulgaria, Chile, Georgia, Hungary, Korea, Republic of, Latvia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Serbia, South Africa, Spain, Taiwan, Ukraine
-
AstraZenecaParexelCompletedLung CancerCanada, Denmark, Italy, Spain, Belgium, Korea, Republic of, Brazil, China, Taiwan, Australia, Austria, United Kingdom, Sweden, Argentina, Saudi Arabia, Ireland
-
PfizerTerminatedPulmonary Arterial Hypertension | Pulmonary HypertensionUnited States, Bulgaria, Argentina, Chile, China, Colombia, Czech Republic, India, Malaysia, Mexico, Peru, Romania, Russian Federation, Serbia, South Africa, Thailand, Turkey, Ukraine
-
Novartis PharmaceuticalsNo longer availableNon-small Cell Lung Cancer (NSCLC)United States, Argentina, Korea, Republic of, Hong Kong, Thailand, Mexico, Jordan, Colombia, India, Philippines
-
PriCara, Unit of Ortho-McNeil, Inc.CompletedPneumonia | Ventilator-Associated Pneumonia | Bacterial Pneumonia | Infections, NosocomialUnited States, Ukraine, Argentina, India, Russian Federation, Croatia, Canada, Chile, France
-
Novartis PharmaceuticalsCompletedLong-term Safety of TIPItaly, Spain, Germany, United States, Australia, Canada, Hungary, Mexico, Argentina
-
Invivyd, Inc.TerminatedCOVID-19Argentina, Brazil, Bulgaria, Germany, Greece, Hungary, Moldova, Republic of, Poland, Romania, South Africa, Ukraine
-
GlaxoSmithKlineActive, not recruitingLung Cancer, Non-Small CellArgentina, Korea, Republic of, Taiwan, France, Spain, Italy, United States, Germany, Romania, Poland, Brazil, Chile
-
Daiichi Sankyo, Inc.CompletedCachexiaUnited States, Argentina, Chile, Guatemala, Honduras, Romania
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, Belgium, South Africa, United States, Russian Federation, France, Slovakia, Spain, Thailand, Czechia, Greece, Argentina, Peru, United Kingdom, Bulgaria, Turkey, Hungary, Vietnam, Philippines, Colombia, Chile
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Romania, Russian Federation, Estonia, Peru, Poland, France, Chile, Hungary, Italy, Slovakia
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Spain, United States, Turkey, Canada, Hungary, Slovakia, Italy, Argentina, Czech Republic, France, Peru
-
Janssen Research & Development, LLCTerminatedRespiratory Tract InfectionsBelgium, Czechia, Taiwan, Japan, Hungary, Thailand, United States, Germany, Korea, Republic of, Turkey, China, Spain, Brazil, Bulgaria, Malaysia, Estonia, Argentina, Poland, Israel, Italy, Latvia, Mexico, Panama, Slovakia, Sweden, Ukraine
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerSpain, France, United States, United Kingdom, Latvia, Italy, Israel, Argentina, Germany
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungAustria, Germany, Spain, China, Taiwan, Argentina, Australia, Belgium, Brazil, Finland, France, Hungary, India, Israel, Italy, Korea, Republic of, Mexico, Netherlands, Peru, Poland, Russian Federation, Ukraine, United Kingdom
-
Synairgen Research Ltd.CompletedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2United Kingdom, Italy, United States, Portugal, Israel, Germany, Belgium, India, Spain, Netherlands, Argentina, Brazil, Colombia, France, Mexico, Romania, Serbia
-
Insmed IncorporatedRecruitingPulmonary Arterial HypertensionArgentina, Austria, Brazil, Germany, Italy, Malaysia, Philippines, Spain, United Kingdom, Serbia, Japan, United States, Mexico, Denmark
-
PfizerCompletedRespiratory Tract InfectionUnited States, Netherlands, Spain, Korea, Republic of, Denmark, Taiwan, Australia, Mexico, Canada, Japan, Finland, Argentina, Brazil, Chile, Gambia, New Zealand, Philippines, South Africa
-
AmgenNo longer availableNon Small-cell Lung Cancer | Locally Advanced Unresectable NSCLC | Locally Advanced Metastatic NSCLCUnited States, Taiwan, Israel, Saudi Arabia, Brazil, Argentina
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
AstraZenecaRecruitingAsthmaDenmark, United States, South Africa, United Kingdom, Argentina, Vietnam, Brazil, Malaysia, Taiwan, France, Germany, Spain, Thailand, Bulgaria, Philippines, Sweden
-
Hoffmann-La RocheCompletedAsthmaKorea, Republic of, United States, Belgium, Czechia, Germany, Peru, Bulgaria, Russian Federation, Argentina, Ukraine, Canada, Poland, South Africa, New Zealand, Romania
-
CTI BioPharmaTerminatedNSCLCUnited States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
-
Melinta Therapeutics, Inc.CompletedCommunity Acquired Bacterial PneumoniaUnited States, Argentina, Bulgaria, Colombia, Dominican Republic, Georgia, Germany, Hungary, Latvia, Peru, Poland, Romania, Russian Federation, Serbia, Slovenia, South Africa, Spain, Ukraine
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Germany, Thailand, France, Belgium, China, Argentina, Greece, Turkey, Malaysia, Portugal, Hungary, Brazil, United States, India
-
AstraZenecaCompletedAsthmaKorea, Republic of, Peru, Philippines, China, Malaysia, Hungary, Japan, Argentina, Thailand, India, Brazil, Costa Rica
-
AstraZenecaCompletedAsthma PatientsUnited States, Mexico, Russian Federation, South Africa, Romania, Ukraine, Japan, Argentina, Slovakia, Brazil
-
SanofiRegeneron PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUkraine, Argentina, Chile, Poland, Russian Federation, Turkey, United States, Australia, Canada, Germany